Literature DB >> 18264675

Plasma derived protein C in severe sepsis: report of two cases.

A Tuttolomondo, A Pinto, D Di Raimondo, P Fernandez, G Licata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18264675     DOI： 10.1007/s11739-008-0107-5

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  20 in total

1.  An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia.

Authors:  B White; W Livingstone; C Murphy; A Hodgson; M Rafferty; O P Smith
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

Review 2.  The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia.

Authors:  M Levi; T van der Poll; H ten Cate; S J van Deventer
Journal:  Eur J Clin Invest       Date:  1997-01       Impact factor: 4.686

Review 3.  Treating patients with severe sepsis.

Authors:  A P Wheeler; G R Bernard
Journal:  N Engl J Med       Date:  1999-01-21       Impact factor: 91.245

Review 4.  Role of coagulation inhibitors in inflammation.

Authors:  C T Esmon
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

5.  Protein C substitution in sepsis-associated purpura fulminans.

Authors:  E Rintala; M Kauppila; O P Seppälä; L M Voipio-Pulkki; V Pettilä; V Rasi; P Kotilainen
Journal:  Crit Care Med       Date:  2000-07       Impact factor: 7.598

Review 6.  Evaluation of the cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom.

Authors:  Colin Green; Jacqueline Dinnes; Andrea L Takeda; Brian H Cuthbertson
Journal:  Int J Technol Assess Health Care       Date:  2006       Impact factor: 2.188

7.  Severe protein C deficiency predicts early death in severe sepsis.

Authors:  William L Macias; David R Nelson
Journal:  Crit Care Med       Date:  2004-05       Impact factor: 7.598

Review 8.  Pathogenesis of disseminated intravascular coagulation in sepsis.

Authors:  M Levi; H ten Cate; T van der Poll; S J van Deventer
Journal:  JAMA       Date:  1993-08-25       Impact factor: 56.272

Review 9.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

Authors:  R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; Mitchell M Levy
Journal:  Crit Care Med       Date:  2004-03       Impact factor: 7.598

10.  Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality.

Authors:  K Fijnvandraat; B Derkx; M Peters; R Bijlmer; A Sturk; M H Prins; S J van Deventer; J W ten Cate
Journal:  Thromb Haemost       Date:  1995-01       Impact factor: 5.249
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.